CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 17  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1250
LYS 10.1250
GLU 20.0597
LEU 30.0141
ARG 40.0128
CYS 50.0294
GLN 60.0330
CYS 70.0267
ILE 80.0308
LYS 90.0313
THR 100.0054
TYR 110.0045
SER 120.0054
LYS 130.0115
PRO 140.0082
PHE 150.0074
HIS 160.0113
PRO 170.0062
LYS 180.0081
PHE 190.0027
ILE 200.0010
LYS 210.0069
GLU 220.0050
LEU 230.0054
ARG 240.0109
VAL 250.0111
ILE 260.0132
GLU 270.0187
SER 280.0064
GLY 290.0092
PRO 300.0333
HIS 310.0161
CYS 320.0203
ALA 330.0257
ASN 340.0204
THR 350.0116
GLU 360.0080
ILE 370.0061
ILE 380.0105
VAL 390.0036
LYS 400.0055
LEU 410.0088
SER 420.0128
ASP 430.0240
GLY 440.0201
ARG 450.0183
GLU 460.0062
LEU 470.0051
CYS 480.0065
LEU 490.0052
ASP 500.0132
PRO 510.0124
LYS 520.0312
GLU 530.0084
ASN 540.0020
TRP 550.0056
VAL 560.0037
GLN 570.0045
ARG 580.0040
VAL 590.0048
VAL 600.0049
GLU 610.0100
LYS 620.0063
PHE 630.0036
LEU 640.0077
LYS 650.0154
ARG 660.0181
ALA 670.0220
GLU 680.0337
ASN 690.0438

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.